[1]
|
Lesnefsky, E.J. (1994) Tissue iron overload and mechanisms of iron catalyzed oxidative injury. Advances in Experimental Medicine and Biology, 366, 129-146.
doi:10.1007/978-1-4615-1833-4_10
|
[2]
|
Britton, R.S., Ramm, G.A., Olynyk, J., Singh, R., O’Neill, R. and Bacon, B.R. (1994) Pathophysiology of iron toxicity. Advances in Experimental Medicine and Biology, 356, 239-253. doi:10.1007/978-1-4615-2554-7_26
|
[3]
|
Emerit, J., Beaumont, C. and Trivin, F. (2001) Iron metabolism, free radicals, and oxidative injury. Biomedicine & Pharmacotherapy, 55, 333-339.
doi:10.1016/S0753-3322(01)00068-3
|
[4]
|
Cederbaum, A.I. (2003) Iron and CYP2E1-dependent oxidative stress and toxicity. Alcohol, 30, 115-120.
doi:10.1016/S0741-8329(03)00104-6
|
[5]
|
Epsztejn, S., Kakhlon, O., Glickstein, H., Breuer, W. and Cabantchik, I. (1997) Fluorescence analysis of the labile iron pool of mammalian cells. Analytical Biochemistry, 248, 31-40. doi:10.1006/abio.1997.2126
|
[6]
|
Gackowski, D., Kruszewsk, M., Banaszkiewicz, Z., Jawien, A. and Olinski, R. (2002) Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients. Acta Biochimica Polonica, 49, 269-272.
|
[7]
|
Lipinski, P., Drapier, J.C., Oliveira, L., Retmanska, H., Sochanowicz, B. and Kruszewski, M. (2000) Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: A study of L5178Y mouse lymphoma cell lines differentially sensitive to H(2)O(2). Blood, 95, 2960-2966.
|
[8]
|
Petrat, F., de Groot, H. and Rauen, U. (2001) Subcellular distribution of chelatable iron: A laser scanning microscopic study in isolated hepatocytes and liver endothelial cells. Biochemical Journal, 356, 61-69.
doi:10.1042/0264-6021:3560061
|
[9]
|
Corradini, E., Ferrara, F. and Pietrangelo, A. (2004) Iron and the liver. Pediatric Endocrinology Reviews, 2, 245-248.
|
[10]
|
Caro, A.A. and Cederbaum, A.I. (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annual Review of Pharmacology and Toxicology, 44, 27-42.
doi:10.1146/annurev.pharmtox.44.101802.121704
|
[11]
|
Srichairatanakool, S., Ounjaijean, S., Thephinlap, C., Khansuwan, U., Phisalpong, C. and Fucharoen, S. (2006) Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload. Hemoglobin, 30, 311-327. doi:10.1080/03630260600642666
|
[12]
|
Khokhar, S., Venema, D., Hollman, P.C., Dekker, M. and Jongen, W. (1997) A RP-HPLC method for the determination of tea catechins. Cancer Letter, 114, 171-172.
doi:10.1016/S0304-3835(97)04653-3
|
[13]
|
Guo, Q., Zhao, B., Li, M., Shen, S. and Xin, W. (1996) Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochimca et Biophysica Acta, 1304, 210- 222. doi:10.1016/S0005-2760(96)00122-1
|
[14]
|
Anghileri, LJ. and Thouvenot, P. (2000) Natural polyphenols-iron interaction: Its biological importance. Biological Trace Element Research, 73, 251-258.
doi:10.1385/BTER:73:3:251
|
[15]
|
Jimenez-Lopez, J.M. and Cederbaum, A.I. (2004) Green tea polyphenol epigallocatechin-3-gallate protects HepG2 cells against CYP2E1-dependent toxicity. Free Radical Biology and Medicine, 36, 359-370.
doi:10.1016/j.freeradbiomed.2003.11.016
|
[16]
|
Higuchi, A., Yonemitsu, K., Koreeda, A. and Tsunenari, S. (2003) Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidation—A mechanism of protective effects of EGCg against paraquat toxicity. Toxicology, 183, 143-149.
doi:10.1016/S0300-483X(02)00512-7
|
[17]
|
Al-Bloushi, S., Safer, A.M., Afzal, M. and Mousa, S.A. (2009) Green tea modulates reserpine toxicity in animal models. Journal of Toxicological Sciences, 34, 77-87.
doi:10.2131/jts.34.77
|
[18]
|
Galati, G., Lin, A., Sultan, A.M. and O’Brien, P.J. (2006) Cellular and in vivo hepatotoxicity caused by green tea phenolic acids and catechins. Free Radical Biology and Medicine, 40, 570-580.
doi:10.1016/j.freeradbiomed.2005.09.014
|
[19]
|
Huang, X., Kojima-Yuasa, A., Xu, S., Norikura, T., Kennedy, D.O., Hasuma, T. and Matsui-Yuasa, I. (2008) Green tea extract enhances the selective cytotoxic activity of Zizyphus jujuba extracts in HepG2 cells. The American Journal of Chinese Medicine, 36, 729-744.
doi:10.1142/S0192415X08006193
|
[20]
|
Ounjaijean, S., Thephinlap, C., Khansuwan, U., Phisalapong, C., Fucharoen, S., Porter, J.B. and Srichairatanakool, S. (2008) Effect of green tea on iron status and oxidative stress in iron-loaded rats. Medicinal Chemistry, 4, 365-370. doi:10.2174/157340608784872316
|
[21]
|
Saewong, T., Ounjaijean, S., Mundee, Y., Pattanapanyasat, K., Fucharoen, S., Porter, J.B. and Srichairatanakool, S. (2010) Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice. Medicinal Chemistry, 6, 57-64.
doi:10.2174/157340610791321479
|
[22]
|
Tyson, C.A., LeValley, S.E., Chan, R., Hobbs, P.D. and Dawson, M.I. (1984) Biological evaluation of some ionophore-polymeric chelator combinations for reducing iron overload. Journal of Pharmacology and Experimental Therapeutics, 228, 676-681.
|
[23]
|
Pippard, M.J., Jackson, M.J., Hoffman, K., Petrou, M. and Modell, C.B. (1986) Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA). Scandinavian Journal of Haematology, 36, 466- 472. doi:10.1111/j.1600-0609.1986.tb02282.x
|
[24]
|
Wonke, B., Wright, C. and Hoffbrand, A.V. (1998) Combined therapy with deferiprone and desferrioxamine. British Journal of Haematology, 103, 361-364.
doi:10.1046/j.1365-2141.1998.01002.x
|
[25]
|
Balveer, K., Pyar, K. and Wonke, B. (2000) Combined oral and parenteral iron chelation in beta thalassaemia major. Medical Journal of Malaysia, 55, 493-497.
|
[26]
|
Wu, D. and Cederbaum, A.I. (2008) Development and properties of HepG2 cells that constitutively express CYP2E1. Methods in Molecular Biology, 447, 137-150.
doi:10.1007/978-1-59745-242-7_11
|
[27]
|
Huang, Z.Z., Chen, C., Zeng, Z., Yang, H., Oh, J., Chen, L. and Lu, S.C. (2001) Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. The FASEB Journal, 15, 19-21.
|
[28]
|
Trinder, D., Batey, R.G., Morgan, E.H. and Baker, E. (1990) Effect of cellular iron concentration on iron uptake by hepatocytes. American Journal of Physiology, 259, G611-G617.
|
[29]
|
McAbee, D.D. and Ling, Y.Y. (1997) Iron-loading of cultured adult rat hepatocytes reversibly enhances lactoferrin binding and endocytosis. Journal of Cellular Physiology, 171, 75-86.
doi:10.1002/(SICI)1097-4652(199704)171:1<75::AID-JCP9>3.0.CO;2-E
|
[30]
|
Staubli, A. and Boelsterli, U.A. (1998) The labile iron pool in hepatocytes: Prooxidant-induced increase in free iron precedes oxidative cell injury. American Journal of Physiology, 274, G1031-1037.
|
[31]
|
Perez-de-Arce, K., Foncea, R. and Leighton, F. (2005) Reactive oxygen species mediates homocysteine-induced mitochondrial biogenesis in human endothelial cells: Modulation by antioxidants. Biochemical and Biophysical Research Communications, 338, 1103-1109.
doi:10.1016/j.bbrc.2005.10.053
|
[32]
|
Petit, T., Izbicka, E., Lawrence, R.A., Nalin, C., Weitman, S.D. and Von Hoff, D.D. (1999) Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units. Anticancer Drugs, 10, 309-315.
doi:10.1097/00001813-199903000-00010
|
[33]
|
Thephinlap, C., Ounjaijean, S., Khansuwan, U., Fucharoen, S., Porter, J.B. and Srichairatanakool, S. (2007) Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stress. Medicinal Chemistry, 3, 289-296.
doi:10.2174/157340607780620608
|
[34]
|
Olivieri, N.F., Brittenham, G.M., Matsui, D., Berkovitch, M., Blendis, L.M., Cameron, R.G., McClelland, R.A., Liu, P.P., Templeton, D.M. and Koren, G. (1995) Iron-chelation therapy with oral deferipronein patients with thalassemia major. The New England Journal of Medicine, 332, 918-922. doi:10.1056/NEJM199504063321404
|
[35]
|
Porter, J.B. (1997) A risk-benefit assessment of ironchelation therapy. Drug Safety, 17, 407-421.
doi:10.2165/00002018-199717060-00006
|
[36]
|
Porter, J.B. (2009) Optimizing iron chelation strategies in beta-thalassaemia major. Blood Reviews, 23, S3-S7.
doi:10.1016/S0268-960X(09)70003-7
|
[37]
|
Scott, B.C., Butler, J., Halliwell, B. and Aruoma, O.I. (1993) Evaluation of the antioxidant actions of ferulic acid and catechins. Free Radical Research Communications, 19, 241-253. doi:10.3109/10715769309056512
|
[38]
|
Valberg, L.S., Ghent, C.N., Lloyd, D.A., Frei, J.V. and Chamberlain, M.J. (1978) Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease. Canadian Medical Association Journal, 119, 229-236.
|
[39]
|
Paterna, J.C., Boess, F., Staubli, A. and Boelsterli, U.A. (1998) Antioxidant and cytoprotective properties of Dtagatose in cultured murine hepatocytes. Toxicology and Applied Pharmacology, 148, 117-125.
doi:10.1006/taap.1997.8315
|
[40]
|
Baker, E., Baker, S.M. and Morgan, E.H. (1998) Characterisation of non-transferrin-bound iron (ferric citrate) uptake by rat hepatocytes in culture. Biochimica et Biophysica Acta, 1380, 21-30.
doi:10.1016/S0304-4165(97)00120-7
|
[41]
|
Richardson, D.R., Chua, A.C. and Baker, E. (1999) Activation of an iron uptake mechanism from transferrin in hepatocytes by small-molecular-weight iron complexes: Implications for the pathogenesis of iron-overload disease. Journal of Laboratory and Clinical Medicine, 133, 144-151. doi:10.1016/S0022-2143(99)90007-0
|
[42]
|
Gaboriau, F., Chantrel-Groussard, K. Rakba, N., Loyer, P., Pasdeloup, N., Hider, R.C., Brissot, P. and Lescoat, G. (2004) Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: A biological and physicochemical study. Biochemical Pharmacology, 67, 1479-1487.
doi:10.1016/j.bcp.2003.12.019
|
[43]
|
Glickstein, H., El, R.B., Shvartsman, M. and Cabantchik, Z.I. (2005) Intracellular labile iron pools as direct targets of iron chelators: A fluorescence study of chelator action in living cells. Blood, 106, 3242-3250.
doi:10.1182/blood-2005-02-0460
|
[44]
|
Brock, J.H., Liceaga, J., Arthur, H.M. and Kontoghiorghes, G.J. (1990) Effect of novel 1-alkyl-3-hydroxy-2- methylpyrid-4-one chelators on uptake and release of iron from macrophages. American Journal of Hematology, 34, 21-25. doi:10.1002/ajh.2830340106
|
[45]
|
Ramirez-Mares, M.V. and de Mejia, E,G. (2003) Comparative study of the antioxidant effect of ardisin and epigallocatechin gallate in rat hepatocytes exposed to benomyl and 1-nitropyrene. Food and Chemical Toxicology, 41, 1527-1535.
doi:10.1016/S0278-6915(03)00169-8
|
[46]
|
Ye, S.F., Hou, Z.Q. and Zhang, Q.Q. (2007) Protective effects of Phellinus linteus extract against iron overload-mediated oxidative stress in cultured rat hepatocytes. Phytotherapy Research, 21, 948-953.
doi:10.1002/ptr.2182
|
[47]
|
Meloche, B.A. and O’Brien, P.J. (1993) S-nitrosyl glutathione-mediated hepatocyte cytotoxicity. Xenobiotica, 23, 863-871. doi:10.3109/00498259309059414
|
[48]
|
Bonkovsky, H.L. and Lambrecht, R.W. (2000) Iron-induced liver injury. Clinics in Liver Disease, 4, 409-429.
doi:10.1016/S1089-3261(05)70116-1
|
[49]
|
de Mejia, E.G. and Ramirez-Mares, M.V. (2002) Leaf extract from Ardisia compressa protects against 1-nitropyrene-induced cytotoxicity and its antioxidant defense disruption in cultured rat hepatocytes. Toxicology, 179, 151-162. doi:10.1016/S0300-483X(02)00242-1
|
[50]
|
Barnum-Huckins, K. and Adrian, G.S. (2000) Iron regulation of transferrin synthesis in the human hepatoma cell line HepG2. Cell Biology International, 24, 71-77.
doi:10.1006/cbir.1999.0456
|
[51]
|
Chang, T.N., Huang, G.J., Ho, Y.L., Huang, S.S., Chang, H.Y. and Chang, Y.S. (2009) Antioxidant and antiproliferative activities of Crossostephium chinensis (L.) Makino. The American Journal of Chinese Medicine, 37, 797-814. doi:10.1142/S0192415X09007259
|
[52]
|
Chen, Q., Galleano, M. and Cederbaum, A.I. (1998) Cytotoxicity and apoptosis produced by arachidonic acid in HepG2 cells overexpressing human cytochrome P-4502E1. Alcoholism: Clinical and Experimental Research, 22, 782- 84. doi:10.1111/j.1530-0277.1998.tb03868.x
|
[53]
|
Chenoufi, N., Drenou, B., Loreal, O., Pigeon, C., Brissot, P. and Lescoat, G. (1998) Antiproliferative effect of deferiprone on the Hep G2 cell line. Biochemical Pharmacology, 56, 431-437.
doi:10.1016/S0006-2952(98)00071-9
|
[54]
|
Cragg, L., Hebbel, R.P., Miller, W., Solovey, A., Selby, S. and Enright, H. (1998) The iron chelator L1 potentiates oxidative DNA damage in iron-loaded liver cells. Blood, 92, 632-638.
|